F

Serial Number 97676154
733

Registration Progress

Application Filed
Nov 14, 2022
Under Examination
Sep 5, 2023
Approved for Publication
Jul 11, 2023
Published for Opposition
Jul 11, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 05, 2026 52 days

Trademark Image

F

Basic Information

Serial Number
97676154
Filing Date
November 14, 2022
Published for Opposition
July 11, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 31, 2025
Application
Pending
Classes
005

Rights Holder

Teijin Pharma Limited

03
Address
2-1, Kasumigaseki 3-chome
Chiyoda-ku, Tokyo 100-0013
JP

Ownership History

Teijin Pharma Limited

Original Applicant
03
Chiyoda-ku, Tokyo JP

Teijin Pharma Limited

Owner at Publication
03
Chiyoda-ku, Tokyo JP

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Deadline
52 days remaining
NOA E-Mailed - SOU Required
Due Date
March 05, 2026
Extension Available
Until September 05, 2026

Application History

30 events
Date Code Type Description Documents
Aug 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 31, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 31, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 31, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 10, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 10, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 9, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 15, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 5, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 4, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 17, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 1, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 17, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of hyperuricemia and gout

Additional Information

Design Mark
The mark consists of stylized letter "F".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005